- Home
- BLFS vs PCT Comparison
BLFS vs PCT Comparison
Compare BLFS & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- PCT
- Stock Information
- Founded
- BLFS 1987
- PCT 2015
- Country
- BLFS United States
- PCT United States
- Employees
- BLFS N/A
- PCT N/A
- Industry
- BLFS Medical/Dental Instruments
- PCT Environmental Services
- Sector
- BLFS Health Care
- PCT Utilities
- Exchange
- BLFS Nasdaq
- PCT Nasdaq
- Market Cap
- BLFS 1.2B
- PCT 1.1B
- IPO Year
- BLFS 1989
- PCT N/A
- Fundamental
- Price
- BLFS $21.91
- PCT $5.99
- Analyst Decision
- BLFS Strong Buy
- PCT Strong Buy
- Analyst Count
- BLFS 7
- PCT 4
- Target Price
- BLFS $30.57
- PCT $12.50
- AVG Volume (30 Days)
- BLFS 612.2K
- PCT 2.6M
- Earning Date
- BLFS 05-08-2025
- PCT 05-06-2025
- Dividend Yield
- BLFS N/A
- PCT N/A
- EPS Growth
- BLFS N/A
- PCT N/A
- EPS
- BLFS N/A
- PCT N/A
- Revenue
- BLFS $82,254,000.00
- PCT N/A
- Revenue This Year
- BLFS $20.32
- PCT N/A
- Revenue Next Year
- BLFS $19.98
- PCT $26.46
- P/E Ratio
- BLFS N/A
- PCT N/A
- Revenue Growth
- BLFS 8.44
- PCT N/A
- 52 Week Low
- BLFS $14.84
- PCT $4.50
- 52 Week High
- BLFS $29.55
- PCT $15.58
- Technical
- Relative Strength Index (RSI)
- BLFS 43.16
- PCT 38.86
- Support Level
- BLFS $21.35
- PCT $5.90
- Resistance Level
- BLFS $23.05
- PCT $6.66
- Average True Range (ATR)
- BLFS 2.03
- PCT 0.71
- MACD
- BLFS 0.02
- PCT 0.02
- Stochastic Oscillator
- BLFS 42.97
- PCT 29.14
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
About PCT PureCycle Technologies Inc. Common stock
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.